Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07727759
What this trial is testing

CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

Who this might be right for
Post-Hepatectomy Liver FailureLiver FailureLiver Neoplasms+4 more
Minia University 1,070
Not applicableUnknownNCT03322280
What this trial is testing

TACE Combined With Iodine-125 Seeds Implantation for HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein OcclusionTumor Thrombus
Second Affiliated Hospital of Guangzhou Medical University 270
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT06006286
What this trial is testing

A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

Who this might be right for
Metastatic Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Not applicableStudy completedNCT04576572
What this trial is testing

Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerAdvanced Adult Hepatocellular Carcinoma+3 more
Inonu University 424
Testing effectiveness (Phase 2)Study completedNCT04542837
What this trial is testing

The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma

Who this might be right for
HCC
Peking University Cancer Hospital & Institute 55
Early research (Phase 1)Study completedNCT06345001
What this trial is testing

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers

Who this might be right for
Hepatocellular Carcinoma (HCC)Solid Tumors
Bayer 14
Large-scale testing (Phase 3)Study completedNCT01721954
What this trial is testing

FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Sirtex Medical 209
Not applicableActive Not RecruitingNCT05953337
What this trial is testing

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectableLiver Cancer
ABK Biomedical 120
Testing effectiveness (Phase 2)Ended earlyNCT02524119
What this trial is testing

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 5
Not applicableStudy completedNCT01908166
What this trial is testing

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Who this might be right for
Adult Primary Liver CancerKidney Tumor
Stanford University 61
Not applicableStudy completedNCT05732181
What this trial is testing

The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation

Who this might be right for
Liver CancerPost Ablation Syndrome
National Cheng-Kung University Hospital 154
Testing effectiveness (Phase 2)Study completedNCT00941967
What this trial is testing

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 78
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Large-scale testing (Phase 3)Study completedNCT00901901
What this trial is testing

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 732
Testing effectiveness (Phase 2)UnknownNCT06124001
What this trial is testing

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

Who this might be right for
Primary Hepatocellular Carcinoma
CNBG-Virogin Biotech (Shanghai) Ltd. 36
Not applicableStudy completedNCT06390228
What this trial is testing

Impact of Hepatectomy on HCC Recurrence

Who this might be right for
Hepatocellular Carcinoma Stage IRecurrence
Anhui Medical University 197
Testing effectiveness (Phase 2)WithdrawnNCT03782831
What this trial is testing

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableUnknownNCT05859945
What this trial is testing

Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Power Life Sciences Inc. 500
Next Page